Medicare Enrolled

Dr. Jeffrey Horvath, M.D.

Rheumatology · Springfield, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
800 N. 1ST STREET, Springfield, IL 62702
2175287541
Registered in NPPES since 2006
NPI: 1588761811 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Horvath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Horvath? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Horvath

Dr. Jeffrey Horvath is a rheumatology specialist in Springfield, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Horvath performed 16,544 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Horvath received a total of $244,118 from 26 pharmaceutical and/or device companies across 1100 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Horvath is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 30% volume in IL $244,118 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
16,544
Medicare services
Top 30% in IL for rheumatology
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
4,875 $34 $78
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
3,550 $11 $69
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,790 $26 $203
Denosumab injection (Prolia/Xgeva) 2,580 $18 $41
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
562 $84 $555
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
325 $6 $291
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
311 $1 $8
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
265 $6 $6
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
186 $92 $679
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
174 $21 $149
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
154 $43 $311
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
107 $1 $5
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
105 $11 $88
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
87 $10 $50
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
70 $9 $41
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
69 $111 $741
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
66 $96 $1,641
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
61 $4 $20
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
53 $58 $453
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
52 $1 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
49 $70 $378
Injection, methylprednisolone acetate, 40 mg 29 $6 $23
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $44 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
70.5% high complexity
23.7% medium
5.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$244,118
Total received (2018-2024)
Avg $34,874/year across 7 years
Top 2% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
1,100
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$34,407
2023
$49,809
2022
$45,537
2021
$19,241
2020
$27,016
2019
$56,019
2018
$12,089

Payments by company (2024)

Amgen Inc.
$30,563
ABBVIE INC.
$2,351
Novartis Pharmaceuticals Corporation
$477
UCB, Inc.
$250
PFIZER INC.
$221
E.R. Squibb & Sons, L.L.C.
$108
Janssen Biotech, Inc.
$95
AstraZeneca Pharmaceuticals LP
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$86
GENZYME CORPORATION
$85
Sandoz Inc.
$50
Fresenius Kabi USA, LLC
$29
Top 3 companies account for 97.0% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$60,784
Novartis Pharmaceuticals Corporation
$48,070
AbbVie, Inc.
$35,359
Amgen Inc.
$32,891
ABBVIE INC.
$32,277
AbbVie Inc.
$26,917
Bioventus LLC
$1,455
UCB, Inc.
$1,162
PFIZER INC.
$961
Genentech USA, Inc.
$664
Lilly USA, LLC
$624
Celgene Corporation
$561
GENZYME CORPORATION
$519
AstraZeneca Pharmaceuticals LP
$480
E.R. Squibb & Sons, L.L.C.
$375
Janssen Biotech, Inc.
$248
Boehringer Ingelheim Pharmaceuticals, Inc.
$159
Sandoz Inc.
$145
SANOFI-AVENTIS U.S. LLC
$134
Aurinia Pharma U.S., Inc.
$110
Fresenius Kabi USA, LLC
$67
GlaxoSmithKline, LLC.
$51
Horizon Pharma plc
$49
MEDAC PHARMA, INC.
$24
Pacira Therapeutics, Inc.
$17
Pacira Pharmaceuticals Incorporated
$14
Top 3 companies account for 59.1% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Enbrel · FORTEO · GELSYN 3 · GELSYN-3 · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · Iovera · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · ORENCIA · Otezla · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SKYRIZI · TALTZ · TREMFYA · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Springfield?
Compare rheumatologists in the Springfield area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
13
County median income
$74,114
Nearest hospital to ZIP centroid (approximate)
MEMORIAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Horvath is a mixed practice specialist, with above-average Medicare volume (top 30% in IL), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Horvath experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Horvath performed 4,875 abatacept infusion (orencia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Horvath receive payments from pharmaceutical companies?
Yes. Dr. Horvath received a total of $244,118 from 26 companies across 1,100 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Horvath's costs compare to other rheumatologists in Springfield?
Dr. Horvath's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Horvath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →